These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18383935)

  • 1. [Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
    Deriaz-Chessex S; Carron P; Gachoud D; Fournier Y; Donzé J; Monti M; Achtari Jeanneret L; Rossier A; Moix PA; Barras-Moret AC; Wilson P
    Rev Med Suisse; 2008 Jan; 4(142):273-4, 276-8. PubMed ID: 18383935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highlights 2008 in a university hospital-based internal medicine: the point of view from the chief residents].
    Wilson P; Bullani R; Cosma M; Deriaz S; Donzé J; Monney C; Neuffer N; Pantet O; Roduit J; Schwab M; Méan M
    Rev Med Suisse; 2009 Jan; 5(188):238-43. PubMed ID: 19267051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium versus salmeterol in COPD.
    Lloret-Linares C; Bergmann JF
    N Engl J Med; 2011 Jun; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656
    [No Abstract]   [Full Text] [Related]  

  • 4. Tiotropium versus salmeterol in COPD.
    Schembri S
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of thromboembolism in heart infarct, cardiomyopathy and atrial fibrillation].
    Straub PW
    Schweiz Med Wochenschr; 1990 Mar; 120(11):365-71. PubMed ID: 2181642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists helping physicians.
    Bowes D
    CMAJ; 2003 Jan; 168(2):151. PubMed ID: 12538538
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial.
    Wilkoff BL; Kudenchuk PJ; Buxton AE; Sharma A; Cook JR; Bhandari AK; Biehl M; Tomassoni G; Leonen A; Klevan LR; Hallstrom AP;
    J Am Coll Cardiol; 2009 Mar; 53(10):872-80. PubMed ID: 19264245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol: its place in asthma management.
    Kamada AK; Spahn JD; Blake KV
    Ann Pharmacother; 1994 Sep; 28(9):1100-2. PubMed ID: 7803888
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 12. To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation.
    Dharmarajan TS; Varma S; Akkaladevi S; Lebelt AS; Norkus EP
    J Am Med Dir Assoc; 2006 Jan; 7(1):23-8. PubMed ID: 16413431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium versus salmeterol in COPD.
    Restrick L; Stern M; Baxter N
    N Engl J Med; 2011 Jun; 364(26):2552; author reply 2553-4. PubMed ID: 21714657
    [No Abstract]   [Full Text] [Related]  

  • 14. Internal Medicine chief residents suggest need to improve health care delivery and public policy education. Internal Medicine Center to Advance Research and Education.
    King BF; Kindig RC; Noah WH; Tuteur PG
    Internist; 1990; 31(7):suppl 3-15. PubMed ID: 10107092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
    Olopade CO
    JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation management during cardiac device surgery: many tastes tolerated?
    van Hemel NM
    Heart Rhythm; 2009 Sep; 6(9):1280-1. PubMed ID: 19656737
    [No Abstract]   [Full Text] [Related]  

  • 18. A word of caution regarding a new long-acting bronchodilator.
    Bone RC
    JAMA; 1994 May; 271(18):1447-8. PubMed ID: 7909854
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
    Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.